- Home
- SOPH vs CATX Comparison
SOPH vs CATX Comparison
Compare SOPH & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOPH
- CATX
- Stock Information
- Founded
- SOPH 2011
- CATX 1983
- Country
- SOPH Switzerland
- CATX United States
- Employees
- SOPH N/A
- CATX N/A
- Industry
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- CATX Medical/Dental Instruments
- Sector
- SOPH Health Care
- CATX Health Care
- Exchange
- SOPH Nasdaq
- CATX Nasdaq
- Market Cap
- SOPH 231.8M
- CATX 239.0M
- IPO Year
- SOPH 2021
- CATX N/A
- Fundamental
- Price
- SOPH $4.63
- CATX $3.87
- Analyst Decision
- SOPH
- CATX Strong Buy
- Analyst Count
- SOPH 0
- CATX 10
- Target Price
- SOPH N/A
- CATX $12.90
- AVG Volume (30 Days)
- SOPH 98.2K
- CATX 835.6K
- Earning Date
- SOPH 11-04-2025
- CATX 11-11-2025
- Dividend Yield
- SOPH N/A
- CATX N/A
- EPS Growth
- SOPH N/A
- CATX N/A
- EPS
- SOPH N/A
- CATX N/A
- Revenue
- SOPH $69,688,000.00
- CATX $1,235,000.00
- Revenue This Year
- SOPH $16.60
- CATX N/A
- Revenue Next Year
- SOPH $18.77
- CATX N/A
- P/E Ratio
- SOPH N/A
- CATX N/A
- Revenue Growth
- SOPH 7.32
- CATX N/A
- 52 Week Low
- SOPH $2.58
- CATX $1.60
- 52 Week High
- SOPH $4.92
- CATX $13.44
- Technical
- Relative Strength Index (RSI)
- SOPH N/A
- CATX 53.74
- Support Level
- SOPH N/A
- CATX $3.37
- Resistance Level
- SOPH N/A
- CATX $3.78
- Average True Range (ATR)
- SOPH 0.00
- CATX 0.20
- MACD
- SOPH 0.00
- CATX 0.04
- Stochastic Oscillator
- SOPH 0.00
- CATX 66.14
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.